Advertisement
Screener

STAAR Surgical Co (STAA) Overview

STAAR Surgical Co (STAA) Overview

  • 4 Apr 2026: Period ending 3 Jul 2026; Estimate (m); Actual 0.16; Beat / miss (m).
  • 3 Jan 2026: Period ending 3 Apr 2026; Estimate (m); Actual 0.10; Beat / miss (m).
  • 28 Jun 2025: Period ending 26 Sept 2025; Estimate (m); Actual 0.18; Beat / miss (m).
  • 29 Mar 2025: Period ending 27 Jun 2025; Estimate (m); Actual -0.34; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$15.29$18.05$21.30$25.14$29.66$35.012025-11-062026-11-06$14.34$22.04$33.90$52.13$80.16$123.272021-11-082026-11-06$8.65$15.70$28.51$51.79$94.05$170.812016-11-072026-11-06$0.76$2.24$6.63$19.58$57.83$170.812006-11-062026-11-06$0.76$2.24$6.63$19.58$57.83$170.811992-02-242026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$25.20
Previous close
$22.43
Change
$2.77
Change (%)
12.35%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

STAA
-2.86%
S&P 500
(m)

1 year

STAA
-16.46%
S&P 500
(m)

3 years

STAA
-44.18%
S&P 500
(m)

5 years

STAA
-82.16%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

3 Jul 2026 ○ Estimate (m) ● Actual 0.16

-1.18-0.80-0.41-0.030.3628 Mar 2025: estimate (m); actual -1.1028 Mar 2025(m)27 Jun 2025: estimate (m); actual -0.3427 Jun 2025(m)26 Sept 2025: estimate (m); actual 0.1826 Sept 2025(m)3 Apr 2026: estimate (m); actual 0.103 Apr 2026(m)3 Jul 2026: estimate (m); actual 0.163 Jul 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
4 Apr 20263 Jul 2026(m)0.16(m)(m)
3 Jan 20263 Apr 2026(m)0.10(m)(m)
28 Jun 202526 Sept 2025(m)0.18(m)(m)
29 Mar 202527 Jun 2025(m)-0.34(m)(m)
28 Dec 202428 Mar 2025(m)-1.10(m)(m)

2 Jan 2026 ○ Estimate (m) ● Actual -1.62

-1.70-1.09-0.480.130.7431 Dec 2021: estimate (m); actual 0.5631 Dec 2021(m)30 Dec 2022: estimate (m); actual (m)30 Dec 2022(m)29 Dec 2023: estimate (m); actual 0.4329 Dec 2023(m)27 Dec 2024: estimate (m); actual -0.4127 Dec 2024(m)2 Jan 2026: estimate (m); actual -1.622 Jan 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
28 Dec 20242 Jan 2026(m)-1.62(m)(m)
30 Dec 202327 Dec 2024(m)-0.41(m)(m)
31 Dec 202229 Dec 2023(m)0.43(m)(m)
31 Dec 202130 Dec 2022(m)0.80(m)(m)
1 Jan 202230 Dec 2022(m)0.80(m)(m)

Revenue vs. Earnings

USD

3 Jul 2026 ■ Revenue 93.53M ■ Earnings 8.06M — Profit margin 8.61%

-30.20M-38.9%15.91M-22.5%62.01M-6.1%108.12M10.4%27 Jun 2025: revenue 44.32M; earnings -16.81M; profit margin -37.93%27 Jun 202526 Sept 2025: revenue 94.73M; earnings 8.88M; profit margin 9.38%26 Sept 20253 Apr 2026: revenue 93.52M; earnings 5.21M; profit margin 5.57%3 Apr 20263 Jul 2026: revenue 93.53M; earnings 8.06M; profit margin 8.61%3 Jul 2026

2 Jan 2026 ■ Revenue 239.44M ■ Earnings -80.45M — Profit margin -33.60%

-128.79M-34.6%37.73M-18.8%204.24M-2.9%370.76M12.9%31 Dec 2021: revenue 230.47M; earnings 27.51M; profit margin 11.94%31 Dec 202129 Dec 2023: revenue 322.42M; earnings 21.35M; profit margin 6.62%29 Dec 202327 Dec 2024: revenue 313.90M; earnings -20.21M; profit margin -6.44%27 Dec 20242 Jan 2026: revenue 239.44M; earnings -80.45M; profit margin -33.60%2 Jan 2026

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$25.20(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$25.20High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning STAA

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
957.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
1.18M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
8.62%*
Total return · month
1.45%*
Total return · quarter
-23.53%*
Total return · half year
25.38%*
Total return · year to date
-2.86%*
Total return · 1 year
-16.46%*
Total return · 3 years
-44.18%*
Total return · 5 years
-82.16%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

STAAR Surgical Co Overview

View more →

(m)

(m)

SEC CIK
718937
Industry (SIC)
3851 Ophthalmic Goods
Country of operation
United States
Business address
1911 WALKER AVE, MONROVIA, California, 91016, United States
Fiscal year end
0102
Phone
6263037902

Similar stocks

Stock NameCountryMarket CapPE Ratio
National Vision Holdings, Inc. (EYE)United States$1.297B
RxSight, Inc. (RXST)United States$0.197B
Innovative Eyewear Inc (LUCY)United States$0.008B
Warby Parker Inc. (WRBY)United States$2.970B
Bausch & Lomb Corp (BLCO)Canada$6.008B-34.58
COOPER COMPANIES, INC. (COO)United States$10.533B24.09